¼¼°èÀÇ °æÀå¿ë ½Ã¸°Áö ½ÃÀå
Enteral Syringes
»óǰÄÚµå : 1766980
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 375 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,222,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,666,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

°æÀå¿ë ½Ã¸°Áö ¼¼°è ½ÃÀåÀº 2030³â±îÁö 22¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 16¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â °æÀå¿ë ½Ã¸°Áö ¼¼°è ½ÃÀåÀº 2024³âºÎÅÍ 2030³â±îÁö CAGR 5.6%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 22¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ÀÏȸ¿ëÀº CAGR 6.3%¸¦ ±â·ÏÇÏ¸ç ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 15¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Àç»ç¿ë °¡´É ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 4.4%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 4¾ï 1,250¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 9.0%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ °æÀå¿ë ½Ã¸°Áö ½ÃÀåÀº 2024³â¿¡´Â 4¾ï 1,250¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGR 9.0%¸¦ ±â·ÏÇϸç 2030³â±îÁö 5¾ï 2,590¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖ°í, ºÐ¼® ±â°£ µ¿¾È CAGRÀº °¢°¢ 3.0%¿Í 4.3%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 4.0%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ °æÀå¿ë ½Ã¸°Áö ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

°æÀå¿ë ½Ã¸°Áö¶õ ¹«¾ùÀ̸ç, ¿Ö ÇÊ¿äÇѰ¡?

°æÀå¿ë ½Ã¸°Áö´Â °æ±¸·Î À½½ÄÀ̳ª ¾à¹°À» ¼·ÃëÇÒ ¼ö ¾ø´Â ȯÀÚÀÇ À§Àå°ü(GI) °ü¿¡ ¾×ü ¿µ¾ç, ¾à¹°, ¼öºÐÀ» Á÷Á¢ Åõ¿©ÇÏ´Â µ¥ »ç¿ëµÇ´Â Ư¼ö ÀÇ·á±â±âÀÔ´Ï´Ù. ÀÏ¹Ý ÁÖ»ç±â¿Í ´Þ¸® Àå¿ë ÁÖ»ç±â´Â À念¾ç ½Ã½ºÅÛ¿¡ ÀûÇÕÇϵµ·Ï Ưº°È÷ ¼³°èµÇ¾î Á¤¸Æ°üÀ̳ª ´Ù¸¥ ÀÇ·á¿ë Æ©ºê¿ÍÀÇ À§ÇèÇÑ ¿ÀÁ¢¼Ó À§ÇèÀ» ÃÖ¼ÒÈ­ÇÕ´Ï´Ù. Àå¿ë ÁÖ»ç±â´Â ÁÖ·Î º´¿øÀ̳ª ÀçÅà °£È£ ÇöÀå¿¡¼­ Á¤È®ÇÑ ¾çÀÇ ¾à¹°À» Åõ¿©Çϰí, °æ°ü ¿µ¾ç Æ©ºê¸¦ ¼¼Ã´Çϰí, °æ°ü ¿µ¾ç Æ©ºê¿¡ Á÷Á¢ º¼·¯½º ¿µ¾çÀ» Åõ¿©ÇÏ´Â µ¥ »ç¿ëµË´Ï´Ù. Àå¿ë ÁÖ»ç±â´Â ÀϹÝÀûÀ¸·Î 1mL¿¡¼­ 60mL±îÁö ´Ù¾çÇÑ Å©±â·Î Á¦°øµÇ¾î ´Ù¾çÇÑ È¯ÀÚÀÇ ¿ä±¸¿Í ¿µ¾ç ÇÁ·ÎÅäÄÝÀ» ÃæÁ·½Ãų ¼ö ÀÖ½À´Ï´Ù. ÀÏȸ¿ë ÁÖ»ç±â´Â ÁßȯÀÚ Ä¡·á¿¡¼­ ±³Â÷ ¿À¿°ÀÇ À§ÇèÀ» ÁÙÀ̱â À§ÇÑ °ÍÀ̸ç, Àç»ç¿ë ÁÖ»ç±â´Â ºñ¿ë È¿À²¼ºÀ¸·Î ÀÎÇØ ÀçÅà ġ·á¿¡¼­ ÀαⰡ ÀÖ½À´Ï´Ù. °æÀå¿ë ½Ã¸°Áö´Â °æÀ念¾ç ¹× ¾à¹° Åõ¿©¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϱ⠶§¹®¿¡ ´Ù¸¥ Àü´Þ ½Ã½ºÅÛ°ú ±¸º°Çϱâ À§ÇØ »ö»óÀ¸·Î ±¸ºÐµÈ µðÀÚÀÎ, µ¶Æ¯ÇÑ Ä¿³ØÅÍ À¯Çü µî ¾ö°ÝÇÑ ¾ÈÀü ±ÔÁ¤ ¹× Ç¥ÁØÀ» ÁؼöÇØ¾ß ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¾ÈÀü ±â´ÉÀº ÀÇ·á ÇöÀå¿¡¼­ ¿ª»çÀûÀ¸·Î Áß¿äÇÑ ¹®Á¦¿´´ø Àå³» ¿ÀÁ¢¼Ó°ú °°Àº ºÎÀÛ¿ëÀ» ¿¹¹æÇÏ´Â µ¥ ÇʼöÀûÀÔ´Ï´Ù.

±â¼úÀÇ ¹ßÀüÀº Àå³» ÁÖ»ç±â µðÀÚÀÎÀ» ¾î¶»°Ô Çü¼ºÇϰí Àִ°¡?

±â¼ú Çõ½ÅÀ¸·Î Àå ÁÖ»ç±âÀÇ µðÀÚÀΰú ±â´ÉÀÌ Å©°Ô °³¼±µÇ¾î ÀÇ·áÁø°ú °£º´ÀÎ ¸ðµÎ¿¡°Ô ´õ ¾ÈÀüÇÏ°í »ç¿ëÇÏ±â Æí¸®ÇØÁ³½À´Ï´Ù. °¡Àå ÁÖ¸ñÇÒ ¸¸ÇÑ ¹ßÀü Áß Çϳª´Â ISO 80369-3 ±ÔÁ¤ÀÇ ÀϺηΠ°³¹ßµÈ ¼¼°èÀûÀ¸·Î ÀÎÁ¤¹Þ´Â Ç¥ÁØÀÎ ENFit(R) Ä¿³ØÅÍÀÇ µµÀÔÀÔ´Ï´Ù. ÀÌ Ä¿³ØÅÍ´Â °æÀå ½Ã½ºÅÛ°ú ºñ°æÀå ½Ã½ºÅÛ °£ÀÇ ±³Â÷ ¿¬°áÀ» ¹æÁöÇϵµ·Ï ¼³°èµÇ¾î °æÀå¿ë ½Ã¸°Áö°¡ Á¤¸Æ ¶óÀο¡ ½Ç¼ö·Î À̾îÁö´Â °ÍÀ» ¹æÁöÇÔÀ¸·Î½á ȯÀÚ ¾ÈÀü¿¡ ´ëÇÑ Áß´ëÇÑ ¹®Á¦¸¦ ÇØ°áÇÕ´Ï´Ù. ¶ÇÇÑ, °æÀå¿ë ½Ã¸°Áö´Â ÇöÀç ¸íÈ®ÇÑ ±×¶óµ¥ÀÌ¼Ç Ç¥½Ã, ÀÎü°øÇÐÀû µðÀÚÀÎ, ¾Ë·¹¸£±â°¡ Àִ ȯÀÚµµ »ç¿ëÇÒ ¼ö ÀÖµµ·Ï ÀÚÀç Ãë±Þ Àç·á¸¦ »ç¿ëÇÏÁö ¾Ê´Â µðÀÚÀÎÀ¸·Î Á¦Á¶µÇ°í ÀÖ½À´Ï´Ù. ÷´Ü ÇÃ¶ó½ºÆ½°ú Æú¸®¸Ó¸¦ »ç¿ëÇÏ¿© ÁÖ»ç±âÀÇ ³»±¸¼º°ú ¹«±Õ¼ºÀ» Çâ»ó½Ã۰í, ÁßȯÀÚ Ä¡·á ºÐ¾ß¿¡¼­ ´õ ³ôÀº ½Å·Ú¼ºÀ» Á¦°øÇÕ´Ï´Ù. ÀϺΠÃֽŠÁÖ»ç±â¿¡´Â ¾ÈÀü ĸ°ú º¯Á¶ ¹æÁö ¾ÁÀÌ ºÎÂøµÇ¾î ÀÖ¾î ¿À¿° ¹× Åõ¾à ¿À·ùÀÇ À§ÇèÀ» ´õ¿í ÁÙÀÏ ¼ö ÀÖ½À´Ï´Ù. ¶Ç ´Ù¸¥ ±â¼ú Æ®·»µå´Â °æÀå¿ë ½Ã¸°Áö ÆßÇÁ¿¡ ½º¸¶Æ® ±â¼úÀ» ÅëÇÕÇÏ¿© ÁÖÀÔ ¼Óµµ¿Í ÁÖÀÔ·®À» Á¤È®ÇÏ°Ô Á¦¾îÇÒ ¼ö ÀÖ°Ô µÈ °ÍÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ÆßÇÁ¿¡´Â Á¾Á¾ µðÁöÅÐ ÀÎÅÍÆäÀ̽º¿Í °ø±Þ ¶óÀÎÀÌ ¸·È÷°Å³ª ²÷¾îÁ³À» ¶§ °£º´Àο¡°Ô °æ°íÇÏ´Â °æº¸ ½Ã½ºÅÛÀÌ ÀåÂøµÇ¾î ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀüÀº Àå³» ÁÖ»ç±â »ç¿ë ¹æ½Ä¿¡ Çõ¸íÀ» ÀÏÀ¸ÄÑ ¾ÈÀü¼º°ú È¿À²¼ºÀ» ³ôÀ̰í, º¸´Ù Á¤È®ÇÑ Àå³» Åõ¾à°ú ¿µ¾ç °ø±ÞÀ» °¡´ÉÇÏ°Ô Çϰí ÀÖ½À´Ï´Ù.

°æÀå¿ë ½Ã¸°Áö´Â ¾î¶² ȯÀÚ¿¡°Ô °¡Àå ¸¹ÀÌ »ç¿ëµÇ´Â°¡?

Àå¿ë ÁÖ»ç±â´Â ´Ù¾çÇÑ È¯ÀÚ ±×·ì, ƯÈ÷ º¹ÀâÇÑ ¿µ¾ç ¹× ¾à¹° °ü¸®°¡ ÇÊ¿äÇÑ È¯ÀÚ ±×·ì¿¡ ÇʼöÀûÀÔ´Ï´Ù. ¼Ò¾Æ ȯÀÚÀÇ °æ¿ì, ÈíÀÎ ¹× ¿¬ÇÏ Àå¾ÖÀÇ À§ÇèÀ¸·Î ÀÎÇØ °æ±¸ ¼·Ãë°¡ ¾ÈÀüÇÏÁö ¾ÊÀº ¾à¹°ÀÇ Åõ¿©»Ó¸¸ ¾Æ´Ï¶ó °æÀå¿ë ½Ã¸°Áö¸¦ ÅëÇÑ ¿µ¾ç °ø±ÞÀÌ ÇÊ¿äÇÑ °æ¿ì°¡ ¸¹½À´Ï´Ù. ³ú¼º¸¶ºñ, ±¸°³¿­, ÁßÁõ À§½Äµµ¿ª·ùÁúȯ(GERD)À» ¾Î°í ÀÖ´Â ¾ÆÀ̵éÀº ÀûÀýÇÑ ¼ºÀå°ú ¹ß´ÞÀ» º¸ÀåÇϱâ À§ÇØ Àå³» ÁÖ»ç±â¸¦ »ç¿ëÇÏ¿© ¼öÀ¯¿Í ¾à¹° Åõ¿©¸¦ Çϰí ÀÖ½À´Ï´Ù. ¸¶Âù°¡Áö·Î, ÁßȯÀÚ½Ç(ICU)¿¡ ÀÖ´Â ÁßÁõ ¼ºÀΠȯÀÚµéÀº Á¾Á¾ Àå³» ÁÖ»ç±â¸¦ »ç¿ëÇÏ¿© ¿µ¾ç Æ©ºê¸¦ ÅëÇØ Á÷Á¢ ¾à¹°°ú ¿µ¾ç º¸ÃæÁ¦¸¦ Åõ¿©¹Þ½À´Ï´Ù. °æÀå¿ë ½Ã¸°Áö´Â ¿¬ÇÏÀå¾Ö(»ïŰ±â ¾î·Á¿î »óÅÂ)³ª ÆÄŲ½¼º´, ¾ËÃ÷ÇÏÀ̸Ӻ´°ú °°Àº ½Å°æÅðÇ༺ ÁúȯÀ» ¾Î°í ÀÖ´Â ³ëÀε鿡°Ôµµ °æ±¸¿µ¾çÀÌ ¾ÈÀüÇÏÁö ¾Ê°Å³ª È¿°úÀûÀÌÁö ¾ÊÀº °æ¿ì ¸Å¿ì Áß¿äÇÕ´Ï´Ù. ¶ÇÇÑ º´¿ø»Ó¸¸ ¾Æ´Ï¶ó Àå±â¿ä¾ç½Ã¼³À̳ª Àç°¡ ¿ä¾ç ÇöÀå¿¡¼­µµ Áö¼ÓÀûÀÎ ¿µ¾ç°ü¸®¿Í º¹¾à°ü¸®¸¦ À§ÇØ °æÀå¿ë ½Ã¸°Áö°¡ ÀÚÁÖ »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ È¯Àڵ鿡°Ô ÃֽŠÀå¿ë ÁÖ»ç±âÀÇ »ç¿ë ÆíÀǼº, ¸íÈ®ÇÑ Ç¥½Ã, ¾ÈÀü¼ºÀº ½ÄÀÌ ¹× Åõ¾à ¿ä¹ýÀ» È®½ÇÈ÷ Áö۴µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ÀÌó·³ Àå¿ë ÁÖ»ç±â´Â ´Ù¾çÇÑ È¯ÀÚ±º¿¡¼­ Çʼö ¿µ¾ç¼Ò ¹× ÀǾàǰÀ» ¾ÈÀüÇϰí È¿°úÀûÀ¸·Î Åõ¿©ÇÒ ¼ö ÀÖµµ·Ï Áö¿øÇÏ´Â Áö¼ÓÀûÀÎ Ä¡·áÀÇ Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù.

°æÀå¿ë ½Ã¸°Áö ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÏ´Â ¿äÀÎÀº ¹«¾ùÀΰ¡?

°æÀå¿ë ½Ã¸°Áö ½ÃÀåÀÇ ¼ºÀåÀº ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡, Àα¸ °í·ÉÈ­, ENFit(R) ȣȯ ÀåÄ¡ÀÇ »ç¿ëÀ» ÃËÁøÇÏ´Â ¾ö°ÝÇÑ ¾ÈÀü ±ÔÁ¦ µî ¿©·¯ °¡Áö ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ÁÖ¿ä ¼ºÀå ¿äÀÎ Áß Çϳª´Â ¾Ï, ½Å°æ Áúȯ, ¼ÒÈ­±â Áúȯ µîÀÇ À¯º´·ü Áõ°¡À̸ç, ÀÌ·¯ÇÑ ÁúȯÀº Àå±âÀûÀÎ °æÀ念¾ç ¹× ¾à¹° °ü¸®°¡ ÇÊ¿äÇÑ °æ¿ì°¡ ¸¹½À´Ï´Ù. ÀÌ¿Í ´õºÒ¾î, ¿µ¾ç½ÇÁ¶¿Í ¿¬ÇÏÀå¾Ö¿¡ Ãë¾àÇÑ ³ëÀÎ Àα¸°¡ Áõ°¡ÇÔ¿¡ µû¶ó ÀÓ»ó ÇöÀå°ú Àç°¡ °£È£ ¸ðµÎ¿¡¼­ Àå¿ë ÁÖ»ç±â¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖÀ¸¸ç, ENFit(R) Ç¥ÁØ Ã¤Åðú °°Àº ±â¼úÀû Áøº¸´Â ´õ ³ôÀº ¾ÈÀü ±âÁØÀ» º¸ÀåÇϰí, ±×µ¿¾È ȯÀÚ ¾ÈÀü¿¡ ½É°¢ÇÑ ¿ì·Á¸¦ ÃÊ·¡Çß´ø À߸øµÈ ¿¬°áÀÇ À§ÇèÀ» °¨¼Ò½ÃÄ×½À´Ï´Ù. ENFit(R) ȣȯ Á¦Ç°À¸·ÎÀÇ ÀüȯÀº ÀÇ·á ±â°üÀÌ »õ·Î¿î ±ÔÁ¤À» ÁؼöÇϱâ À§ÇØ Àç°í¸¦ ¾÷µ¥ÀÌÆ®Çϸ鼭 ¼ö¿ä°¡ ±ÞÁõÇϰí ÀÖÀ¸¸ç, ÀÌ´Â ½ÃÀå È®´ë¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù. ¶Ç ´Ù¸¥ ¼ºÀå ¿äÀÎÀº ÀÇ·áºñ Àý°¨°ú ȯÀÚ ÆíÀǼº Çâ»ó¿¡ ´ëÇÑ ¿ä±¸·Î ÀÎÇØ ÀçÅà Àå·ç Äɾ ´ëÇÑ ¼±È£µµ°¡ ³ô¾ÆÁö°í ÀÖ´Ù´Â Á¡ÀÔ´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼´Â °£º´ÀÎÀÌ Áý¿¡¼­ ½±°Ô °ü¸®ÇÒ ¼ö ÀÖ´Â »ç¿ëÀÚ Ä£È­ÀûÀÎ Àå¿ë ÁÖ»ç±âÀÇ º¸±ÞÀ» ÃËÁøÇÏ¿© Á¦Á¶¾÷üµé¿¡°Ô »õ·Î¿î ½ÃÀå ºÎ¹®À» âÃâÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ƯÈ÷ ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ÀÇ·áºñ ÁöÃâ Áõ°¡¿Í °æÀ念¾ç ¾ÈÀü ÇÁ·ÎÅäÄÝ¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó Àü ¼¼°èÀûÀ¸·Î °æÀå¿ë ½Ã¸°Áö äÅÃÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ȯÀÚº° ¸ÂÃãÇü °æÀ念¾ç ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó °æÀå¿ë ½Ã¸°Áö ½ÃÀåÀº ¾ÈÀü ±ÔÁ¦, ±â¼ú Çõ½Å, ÁøÈ­Çϴ ȯÀÚ Ä¡·á Æ®·»µåÀÇ °áÇÕÀ¸·Î Áö¼ÓÀûÀÎ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù.

ºÎ¹®

Á¦Ç° À¯Çü(ÀÏȸ¿ë, Àç»ç¿ë °¡´É), ¿ëµµ(¾Ï, ¿µ¾ç ºÒ·®, ½Å°æÁúȯ, ¼ÒÈ­±â °ü·Ã Áúȯ, ±âŸ ¿ëµµ), ÃÖÁ¾ ¿ëµµ(º´¿ø¡¤¿Ü·¡ ÄÉ¾î ¼¾ÅÍ, ÀçÅà »ç¿ëÀÚ)

Á¶»ç ´ë»ó ±â¾÷ »ç·Ê

AI ÅëÇÕ

Global Industry Analysts´Â °ËÁõµÈ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI ÅøÀ» ÅëÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ Çõ½ÅÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀϹÝÀûÀÎ LLM ¹× ¾÷°è °íÀ¯ÀÇ SLM Äõ¸®¸¦ µû¸£´Â ´ë½Å ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾çÀÇ ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¸ÅÃâ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû ¹× °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Enteral Syringes Market to Reach US$2.2 Billion by 2030

The global market for Enteral Syringes estimated at US$1.6 Billion in the year 2024, is expected to reach US$2.2 Billion by 2030, growing at a CAGR of 5.6% over the analysis period 2024-2030. Disposable, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$1.5 Billion by the end of the analysis period. Growth in the Reusable segment is estimated at 4.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$412.5 Million While China is Forecast to Grow at 9.0% CAGR

The Enteral Syringes market in the U.S. is estimated at US$412.5 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$525.9 Million by the year 2030 trailing a CAGR of 9.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.0% and 4.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.0% CAGR.

Global Enteral Syringes Market - Key Trends and Drivers Summarized

What Are Enteral Syringes and Why Are They Essential?

Enteral syringes are specialized medical devices used for administering liquid nutrition, medications, and fluids directly into the gastrointestinal (GI) tract of patients who cannot ingest food or drugs orally. Unlike standard syringes, enteral syringes are specifically designed to ensure compatibility with enteral feeding systems, minimizing the risk of dangerous misconnections with intravenous or other medical tubing. They are primarily used in both hospital and homecare settings for delivering precise doses of medications, flushing feeding tubes, or administering bolus nutrition directly through a feeding tube. Enteral syringes come in various sizes, typically ranging from 1 mL to 60 mL, to accommodate different patient needs and feeding protocols. These syringes are available in single-use and reusable formats, each serving distinct purposes: single-use syringes are intended to reduce cross-contamination risks in critical care settings, while reusable options are popular in homecare due to their cost-effectiveness. Due to their critical role in enteral feeding and medication administration, enteral syringes must adhere to stringent safety regulations and standards, including color-coded designs and unique connector types to distinguish them from other delivery systems. These safety features are integral to preventing adverse events such as enteral misconnections, which have historically been a significant concern in medical practice.

How Are Technological Advancements Shaping Enteral Syringe Design?

Technological innovations have led to substantial improvements in enteral syringe design and functionality, making them safer and more user-friendly for both healthcare professionals and caregivers. One of the most notable advancements is the introduction of the ENFit® connector, a globally recognized standard developed as part of the ISO 80369-3 regulations. This connector is designed to prevent cross-connections between enteral and non-enteral systems, addressing a major patient safety issue by ensuring that enteral syringes cannot be mistakenly attached to intravenous lines. Additionally, enteral syringes are now manufactured with clear gradation markings, ergonomic designs for better handling, and non-latex materials to accommodate patients with allergies. The use of advanced plastics and polymers has also improved the durability and sterility of syringes, enhancing their reliability in critical care applications. Some modern syringes come with safety caps and tamper-proof seals, further reducing the risk of contamination and medication errors. Another technological trend is the integration of smart technology in enteral syringe pumps, which enables precise control over fluid delivery rates and volumes. These pumps often include digital interfaces and alarm systems to alert caregivers if there are blockages or disconnections in the feeding line. Collectively, these advancements are revolutionizing the way enteral syringes are utilized, offering heightened safety and efficiency, and enabling more accurate enteral medication and nutrition delivery.

Which Patient Groups Rely on Enteral Syringes the Most?

Enteral syringes are indispensable for a wide array of patient groups, particularly those with complex nutritional and medication administration needs. Pediatric patients often require enteral syringes for bolus feeding, as well as for administering medications that cannot be safely ingested orally due to risks of aspiration or difficulty swallowing. Children with conditions such as cerebral palsy, cleft palate, or severe gastroesophageal reflux disease (GERD) rely on enteral syringes for feeding and drug administration to ensure adequate growth and development. Similarly, critically ill adults in intensive care units (ICUs) often depend on enteral syringes for delivering medications and nutritional supplements directly through their feeding tubes. Enteral syringes are also crucial for elderly patients with dysphagia (difficulty swallowing) or neurodegenerative conditions like Parkinson’s disease and Alzheimer’s, where oral feeding is either unsafe or ineffective. Beyond the hospital environment, patients in long-term care facilities and homecare settings frequently use enteral syringes for ongoing nutritional and medication management. For these patients, the ease of use, clear labeling, and safety features of modern enteral syringes play a pivotal role in ensuring adherence to feeding and medication regimens. Thus, enteral syringes are a vital tool in the continuum of care, supporting the safe and effective administration of essential nutrients and pharmaceuticals across diverse patient demographics.

What Factors Are Driving the Growth of the Enteral Syringe Market?

The growth in the enteral syringe market is driven by several factors, including the increasing prevalence of chronic diseases, the aging population, and stringent safety regulations promoting the use of ENFit®-compatible devices. One of the primary growth drivers is the rising incidence of conditions like cancer, neurological disorders, and gastrointestinal diseases, which often require long-term enteral nutrition and medication management. This, coupled with the expanding geriatric population that is more susceptible to malnutrition and swallowing difficulties, has increased the demand for enteral syringes in both clinical and homecare settings. Technological advancements, such as the adoption of the ENFit® standard, have further fueled market expansion by ensuring higher safety standards and reducing the risk of misconnections, which historically posed significant patient safety concerns. The transition to ENFit®-compliant products has created a surge in demand as healthcare facilities update their inventory to comply with these new regulations. Another growth driver is the rising preference for home-based enteral care, driven by the need to reduce healthcare costs and improve patient comfort. This trend has led to a higher uptake of user-friendly enteral syringes that caregivers can easily manage at home, creating a new market segment for manufacturers. Additionally, increasing healthcare expenditure, particularly in emerging markets, and the rising awareness of enteral feeding safety protocols are supporting the adoption of enteral syringes worldwide. As the demand for personalized and patient-specific enteral solutions grows, the enteral syringe market is set to see sustained expansion, driven by a confluence of safety regulations, technological innovation, and evolving patient care trends.

SCOPE OF STUDY:

The report analyzes the Enteral Syringes market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Disposable, Reusable); Application (Cancer, Malnutrition, Neurological Disease, GI Related Disease, Other Applications); End-Use (Hospitals & Ambulatory Care Centers, Home-based Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â